Liz Galle is VP OF GLOBAL CLINICAL RESEARCH of CVRx, Inc.. Currently has a direct ownership of 778 shares of CVRX, which is worth approximately $8,114. The most recent transaction as insider was on Oct 16, 2023, when has been sold 778 shares (Common Stock) at a price of $0.24 per share, resulting in proceeds of $186. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 778
0% 3M change
n/a 12M change
Total Value Held $8,114

Liz Galle Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 16 2023
BUY
Exercise of conversion of derivative security
$186 $0.24 p/Share
778 Added 50.0%
778 Common Stock
LG

Liz Galle

VP OF GLOBAL CLINICAL RESEARCH
Minneapolis, MN

Track Institutional and Insider Activities on CVRX

Follow CVRx, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CVRX shares.

Notify only if

Insider Trading

Get notified when an Cv Rx, Inc. insider buys or sells CVRX shares.

Notify only if

News

Receive news related to CVRx, Inc.

Track Activities on CVRX